Cargando…

Pericardial Effusion During the Perioperative Period for Left Atrial Appendage Closure

Objectives: To analyze the predictors of pericardial effusion (PE) during the perioperative period of the left atrial appendage closure procedure in our center. Methods: A total of 624 consecutive patients with non-valvular AF undergoing LAAC from May 2014 to October 2019 were involved in this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lifan, Zhang, Xiaochun, Jin, Qinchun, Kong, Dehong, Zhang, Yuan, Li, Mingfei, Zhang, Lei, Chen, Shasha, Pan, Wenzhi, Zhou, Daxin, Ge, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365031/ https://www.ncbi.nlm.nih.gov/pubmed/34409074 http://dx.doi.org/10.3389/fcvm.2021.678460

Ejemplares similares

Impact of Thrombocytopenia in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison of 190 Consecutive Watchman Implantations
por: Zhang, Xiaochun, et al.
Publicado: (2021)

Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device
por: Yu, Yibo, et al.
Publicado: (2023)

The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure
por: Li, Xiaoye, et al.
Publicado: (2021)

Clinical outcomes of bivalirudin versus heparin in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion
por: Zhang, Xiaochun, et al.
Publicado: (2021)

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation
por: Li, Xiaoye, et al.
Publicado: (2021)

Closure Device-Related Thrombosis After Anticoagulation With Dabigatran in Patients Undergoing Percutaneous Left Atrial Appendage Closure: Case Reports and Literature Review
por: Li, Xiaoye, et al.
Publicado: (2020)

Aortic valve morphology and paravalvular leak regression after a self-expandable transcatheter aortic valve replacement
por: Jin, Qinchun, et al.
Publicado: (2023)

Left atrial appendage closure device complicated by late-onset pericardial effusion and tamponade: a case report
por: Albani, Stefano, et al.
Publicado: (2021)

Pulmonary artery pressure is associated with mid-term major adverse cardiovascular events and postprocedure pericardial effusion in atrial fibrillation patients undergoing left atrial appendage occlusion
por: Zou, Tian, et al.
Publicado: (2021)

Case report: Intrapericardial thrombus aspiration in early stage of pericardial thrombosis for cardiac tamponade complicating percutaneous left atrial appendage closure
por: Mo, Bin-Feng, et al.
Publicado: (2022)

Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus
por: Jin, Lu-Shen, et al.
Publicado: (2022)

Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
por: Wang, Xiaoyan, et al.
Publicado: (2021)

Percutaneous Left Atrial Appendage Closure With a Novel LAA Occluder for Stroke Prevention in Atrial Fibrillation
por: Zhang, Xiaochun, et al.
Publicado: (2022)

Identification of recurrent variants implicated in disease in bicuspid aortic valve patients through whole-exome sequencing
por: Chen, Shasha, et al.
Publicado: (2022)

Effect of Left Atrial Appendage Closure in Combination With Catheter Ablation on Left Atrial Function for Persistent Atrial Fibrillation
por: Yang, Jing, et al.
Publicado: (2021)

Percutaneous Retrieval of Left Atrial Appendage Closure Devices in Patients With Atrial Fibrillation: A Case Report
por: Wang, Saihua, et al.
Publicado: (2022)

Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
por: Berti, Sergio, et al.
Publicado: (2022)

Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
por: Jeelani, Hafiz, et al.
Publicado: (2022)

Huge and late thrombus after percutaneous closure of left atrial appendage
por: Di Valentino, Marcello, et al.
Publicado: (2023)

Diagnostic Value of Interferon-γ Release Assays on Pericardial Effusion for Diagnosis of Tuberculous Pericarditis
por: Bian, Sainan, et al.
Publicado: (2016)

Left Atrial Spontaneous Echo Contrast and Ischemic Stroke in Patients Undergoing Percutaneous Left Atrial Appendage Closure
por: Wang, Binhao, et al.
Publicado: (2021)

Clinical outcomes of bicuspid versus tricuspid aortic valve stenosis after transcatheter aortic valve replacement with self-expandable valves
por: Jin, Qinchun, et al.
Publicado: (2022)

Correction: Clinical outcomes of bicuspid versus tricuspid aortic valve stenosis after transcatheter aortic valve replacement with self‑expandable valves
por: Jin, Qinchun, et al.
Publicado: (2023)

Pericardial Tuberculoma: Transition from Asymptomatic Pericardial Effusion to Pericardial Mass
por: Lim, Kyunghee, et al.
Publicado: (2021)

An updated meta-analysis of device related thrombus following left atrial appendage closure in patients with atrial fibrillation
por: Zhang, Song, et al.
Publicado: (2022)

Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices
por: Ke, Jin-Yan, et al.
Publicado: (2022)

Two-Year Outcome From Combining Cryoballoon Ablation and Left Atrial Appendage Closure: CLACBAC Study
por: Ren, Zhongyuan, et al.
Publicado: (2021)

Left Atrial Appendage Closure for Primary and Secondary Stroke Prevention in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Pilot Study
por: Mo, Bin-Feng, et al.
Publicado: (2021)

Recurrent Pericardial and Pleural Effusion due to Pericardial Pleomorphic Mesothelioma
por: Segura-Méndez, Bárbara, et al.
Publicado: (2022)

Cardiac magnetic resonance imaging for preprocedural planning of percutaneous left atrial appendage closure
por: Bertsche, Dagmar, et al.
Publicado: (2023)

Left atrial appendage sizing for percutaneous closure in virtual reality—a feasibility study
por: Heidari, Houtan, et al.
Publicado: (2023)

Case Report: Thromboembolism and Hemorrhagic Pericardial Effusion—The Janus Face of Primary Pericardial Angiosarcoma
por: Chen, Fei F., et al.
Publicado: (2021)

Preliminary Implantation of a Novel TAVR Device With Polymeric Leaflets for Symptomatic Calcific Aortic Disease
por: Ge, Junbo, et al.
Publicado: (2023)

The feasibility and safety of combining atrial septal defect/patent foramen ovale and left atrial appendage closure: A systematic review and meta-analysis
por: Song, Yi, et al.
Publicado: (2023)

Minimally invasive epicardial left-ventricular lead implantation and simultaneous left atrial appendage closure
por: Petersen, Johannes, et al.
Publicado: (2023)

Recurrent Left Pleural Effusion Following Left Atrial Appendage Closure With the Watchman Device
por: Halaby, Rim, et al.
Publicado: (2020)

Pleuropericardial Window Prevents Pericardial Effusion Following Surgical Atrial Septal Defect Closure
por: Özkan, Murat, et al.
Publicado: (2022)

Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
por: Abelson, Mark
Publicado: (2013)

Multimodality Imaging for Pericardial Epithelioid Angiosarcoma Presenting With Pericardial Effusion and Constrictive Pericarditis
por: Kim, Se-Eun, et al.
Publicado: (2022)

A newly designed disk-lobe occluder with isogenous barbs for left atrial appendage closure: Initial multicenter experience
por: Bai, Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_01peq5mqfn0altsu591g4att21